Bellerophon Therapeutics, Inc. in its Annual meeting of shareholders held on June 1, 2022 elected Mary Ann Cloyd and Crispin Teufel to serve on the Company's board of directors for a three-year term until the Company's 2025 annual meeting of stockholders and until each of their respective successors is duly elected and qualified.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0605 USD | +0.83% | +2.37% | +63.51% |
05-02 | North American Morning Briefing : Stock Futures -2- | DJ |
04-25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+63.51% | 734K | |
+14.19% | 118B | |
+13.49% | 106B | |
-2.45% | 24.28B | |
+0.73% | 21.96B | |
-9.00% | 18.16B | |
-42.12% | 16.37B | |
-17.41% | 15.56B | |
+5.40% | 13.63B | |
+30.94% | 12.27B |
- Stock Market
- Equities
- BLPH Stock
- News Bellerophon Therapeutics, Inc.
- Bellerophon Therapeutics, Inc. Announces New Board Appointment